China Resources Pharma (03320) announced the first three quarters 2026 results of China Resources Double-Crane Pharmaceutical Co., Ltd., with total operating revenue of approximately 8.066 billion yuan, down 4% year-on-year.

Net profit was approximately 1.307 billion yuan, down 6.51% year-on-year.